Results 81 to 90 of about 2,328 (144)

Reversions of QuantiFERON-TB Gold Plus in tuberculosis contact investigation: A prospective multicentre cohort study. [PDF]

PLoS One, 2023
Pérez-Recio S, Grijota-Camino MD, Anibarro L, Rabuñal-Rey R, Sabria J, Gijón-Vidaurreta P, Pomar V, García-Gasalla M, Domínguez-Castellano Á, Trigo M, Santos MJ, Cebollero A, Rodríguez S, Moga E, Penas-Truque A, Martos C, Ruiz-Serrano MJ, Garcia-de-Cara EI, Alcaide F, Santin M.   +19 more
europepmc   +1 more source

Evaluation of QIAreach QuantiFERON-TB lateral-flow nanoparticle fluorescence assay for TB infection diagnosis among TB household contacts in three high-burden settings.

PLoS ONE
BackgroundTuberculosis infection (TBI) testing, and treatment are fundamental to achieve TB elimination. TBI testing among close or household contacts (HHCs) has been limited, in part due to perceived complexity and high operational cost.
Thobani Ntshiqa, Akinlolu Fasanmi, Jeniffer Nagudi, Lindiwe Tsope, Andrew Copas, Stacie Stender, Issa Sabi, Elias Nyanda Ntinginya, Julieth Lalashowi, Manthomeng Matete, Lula Budiaki, Malebo Mahlalela, Abisai Kisinda, Don Mudzengi, Lilian Tina Minja, Tobias Chirwa, Knut Lönnroth, Stefan Niemann, Viola Dreyer, Salome Charalambous, Kavindhran Velen, Yohhei Hamada, Molebogeng Rangaka   +22 more
doaj   +1 more source

Erratum for Buron and Banaei, "Inflated Gamma Interferon Response with QuantiFERON-TB Gold Plus Using the Automated Liaison XL Analyzer: a Testing Algorithm To Mitigate False-Positive Results in Low-Incidence Settings". [PDF]

J Clin Microbiol, 2023
Buron V, Banaei N.
europepmc   +1 more source

Reversions of QuantiFERON-TB Gold Plus in tuberculosis contact investigation

Interferon-y Release Assays (IGRA) reversions have been reported in different clinical scenarios for the diagnosis of tuberculosis (TB) infection. This study aimed to determine the rate of QuantiFERON-TB Gold Plus (QFT-Plus) reversions during contact investigation as a potential strategy to reduce the number of preventive treatments.
Pérez-Recio, Sandra, Grijota-Camino, Maria D.||, Anibarro, Luis||, Rabuñal, Ramón||, Sabria, Josefina, Gijón-Vidaurreta, Paloma, Pomar, Virginia||, García-Gasalla, Mercedes||, Domínguez-Castellano, Ángel M., Trigo-Daporta, Matilde||, Santos, María Jesús, Cebollero, Alba, Rodríguez, Sara, Moga, Esther||, Penas-Truque, Antón, Martos, Carmen, Ruiz-Serrano, María Jesús, Garcia-De-Cara, Erika Inés, Alcaide, Fernando||, Santin, M.   +19 more
openaire   +1 more source

Comparison of diagnostic accuracy of QuantiFERON-TB Gold Plus and T-SPOT.TB in the diagnosis of active tuberculosis in febrile patients. [PDF]

J Evid Based Med, 2022
Zhang L, Yang Z, Bao X, Ma H, Ge Q, Zhang Y, Cao Q, Gao M, Liu X.   +8 more
europepmc   +1 more source

Post-market surveillance for literature on QuantiFERON TB Gold Plus: what improvements can artificial intelligence bring? [PDF]

IJTLD Open
Reniewicz J, Alagna R, Kordylas L, Latacz M, Suryaprakash V, Nowak U, Kois-Ostrowska A, Weleszczuk J, Blacha A, Nikolayevskyy V.   +9 more
europepmc   +1 more source

Positivity rate of QuantiFERON-TB Gold Plus^® test among candidates for biotherapy and factors influencing results. [PDF]

SAGE Open Med
Mezenner H, Ait Hamoudi H, Naamoune S, Abbadi M, Khedimallah M, Belhocine K, Zobiri S, Meddour Y, Taright S, Salah SS.   +9 more
europepmc   +1 more source

Characteristics of indeterminate QuantiFERON-TB Gold PLUS results in pediatric lupus nephritis at Beijing Children's Hospital, 2023-2024. [PDF]

BMC Nephrol
Xi Y, Zheng H, Wang Y, Guo Y, Xiao J, Li F, Qi H, Jiao W, Zhou N, Chen Z, Sun L.   +10 more
europepmc   +1 more source

High prevalence of latent tuberculosis using the QuantiFERON-TB Gold Plus test in Takayasu arteritis. [PDF]

Arch Rheumatol, 2022
Souza Pedreira AL, Pinheiro Leal Costa R, Filipe Pitanga Silva J, Barreto Santiago M.   +3 more
europepmc   +1 more source

Inflated Gamma Interferon Response with QuantiFERON-TB Gold Plus Using the Automated Liaison XL Analyzer: a Testing Algorithm To Mitigate False-Positive Results in Low-Incidence Settings. [PDF]

J Clin Microbiol, 2023
Buron V, Banaei N.
europepmc   +1 more source